The 2011 meeting of the WRI focused on the issues surrounding antiretroviral (ARV) use in women for the prevention and treatment of HIV disease. This theme was selected in order to encompass the broad range of interdisciplinary work that is both ongoing and necessary to effectively prevent and manage HIV disease in women. Although the development of an impressive range of effective ARV drugs has created the possibility of a chronic disease state, the realities of access, uptake, manageability, acceptability and long-term effectiveness prevent us from achieving this desired outcome. This makes it incumbent upon all stakeholders to take a more comprehensive approach to HIV research, including among women.
The 2011 Annual WRI Meeting took place from March 17-20 in Adairsville, GA with 22 members of the WRI participating (including representatives from clinical care, HIV research, academia, community-based organizations, government, the pharmaceutical industry and HIV-positive women), as well as guest speakers and invited experts. A list of the 2011 WRI Meeting members, speakers and participants can be found below.
Click the appropriate link below to view the Executive Summary or Full Summary Report from the 2011 WRI Annual Meeting. We've also included links to brief interviews/testimonials from a few WRI participants about their experiences at the meeting, photos from the meeting and some video clips shared with participants to provide inspiration (or sometimes just a laugh after a long day!).
2011 WRI Executive Summary (807 KB)
2011 WRI Full Summary Report (1 MB)
Video clips shown during the 2011 WRI Meeting
To highlight the most critical research efforts and findings of the past year, invited expert speakers and WRI members presented their work on key topics in biologic, behavioral and social research in women and HIV. Each of these talks fueled rich discussion and often culminated in unique synthesis and perspective by the group.
Invited speakers and topics included:
- PrEP and Microbicides: Sharon Hillier, PhD, University of Pittsburgh Department of OB/Gyn/RS and Microbiology and Molecular Genetics. Reviewed recent and ongoing research into biomedical prevention with a focus on women; addressed implications for pregnancy; described the difference between options and choice for HIV prevention tools among women
- Biologic Correlates of Risk and Aging; Amie L. Meditz, MD, Division of Infectious Diseases, University of Colorado Denver. Evaluated the role of CCR5 and CD4 T-cells in HIV acquisition among post-menopausal women
- Contextualizing the WRI: Key Science and Policy Issues; Judith Auerbach, PhD, San Francisco AIDS Foundation. Described key current relevant science and policy factors, including recent biomedical prevention advances, National HIV/AIDS Strategy, Patient Protection and Affordable Care Act of 2010, federal HIV research funding
- Overview of Cohorts of HIV-infected Women and Girls; Monica Gandhi MD, MPH, Divisions of HIV/AIDS and Infectious Diseases; HIV Consult Service, University of California, San Francisco; presented by Gina Brown, MD, Office of AIDS Research, NIH. Described data generated by NIH cohorts, NIH-funded clinical trial cohorts and other cohorts from around the world
2011 WRI Meeting Participants
Erika Aaron, MSN, CRNP (WRI attendee)
Drexel University College of Medicine
Kathryn Anastos, MD (WRI member)
Montefiore Medical Center
Laura Armas- Kolostroubis, MD* (WRI member)
Texas/Oklahoma AIDS Education and Training Center
Judith Auerbach, PhD* (WRI member and speaker)
San Francisco AIDS Foundation
Richard Averitt (WRI team)
The Well Project
Julie Barroso, PhD, ANP, APRN, BC, FAAN (WRI member)
Duke University School of Nursing
Dawn Averitt Bridge* (WRI member)
The Well Project
Gina Brown, MD* (WRI member and speaker)
Office of AIDS Research, NIH
Susan E. Cohn, MD, MPH (WRI member)
Northwestern University Feinberg School of Medicine
Elizabeth Connick, MD (WRI member)
University of Colorado Denver
Jenna Conley (WRI team)
Conley Communications
Debbie Cooke, CMP (WRI team)
Meeting Masters
Rebecca Denison (WRI member)
WORLD
Dazon Dixon Diallo (WRI attendee)
SisterLove, Inc.
Shari Dworkin, PhD, MS (WRI member)
University of California, San Francisco
Shalini Eddens, MPH (WRI team)
The Well Project
Judith Feinberg, MD* (WRI member)
University of Cincinnati
Carrie Elizabeth Foote, PhD (WRI member)
Indiana University-Indianapolis
Yasmin Halima, MPH (WRI member)
Global Campaign for Microbicides
Sharon Hillier, PhD (WRI member and speaker)
University of Pittsburg Medical Center
Rowena Johnston, PhD (WRI member)
amfAR - The Foundation for AIDS Research
Alan Landay, PhD (WRI member)
Rush University Medical Center
Sharon Lee, MD (WRI member)
Family Health Care
Sandra N. Lehrman (WRI attendee)
Merck and Co., Inc.
Krista Heitzman Martel (WRI team)
The Well Project
Louise Martin-Carpenter (WRI attendee)
ViiV Healthcare
Henry L. Masters III, MD (WRI attendee)
Boehringer Ingelheim
Amie Lynne Meditz, MD (WRI attendee and speaker)
University of Colorado Denver
Caroline Mitchell, MD, MPH (WRI member)
University of Washington
Harborview OB/GYN
Tonia Poteat, PA-C, MPH (WRI member)
Chase Brexton Health Services
Kim Reed (TWP Board Member, WRI attendee)
Reed International Law and Consulting, LLC
Maura Riordan (TWP Board Member, WRI attendee)
AIDS United
Monica Ruiz, PhD, MPH (WRI member)
George Washington University
Valerie Scott (TWP Board Member, WRI attendee)
The Strategic Continuum Company
Kathleen Squires, MD (WRI member)
Thomas Jefferson University
Stephen P. Storfer, MD* (WRI member)
WRI Executive Committee
Kimberly Struble, PharmD (WRI member)
Food and Drug Administration (FDA)
Jonathan Uy, MD (WRI attendee)
Bristol-Myers Squibb
Fulvia Veronese, PhD (WRI attendee)
NIH, NIAID, DAIDS
Kirsten White, PhD (WRI attendee)
Gilead Sciences, Inc.
Charles Wira, PhD (WRI member)
Dartmouth Medical School
* 2011 WRI Executive Committee member
